bpc-157 mechanism of action research Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts bpc-157 mechanism of action effects
Description
Karel Zinek (Neurosanatio s.r.o., Litomyl)
Availability of data and materials All data are included within the article
Start your evaluation today
The World Anti-Doping Agency (WADA) includes it under the category of S0 Non-approved Substances, which covers any pharmacological agent that has not been approved for human use by a regulatory authority
